Takahiro Suzuki

Sagamihara, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Disseminated varicella-zoster virus infection with gastrointestinal prodromal symptoms during daratumumab therapy for relapsed and refractory multiple myeloma.

Disseminated varicella-zoster virus infection with gastrointestinal prodromal symptoms during daratumumab therapy for relapsed and refractory multiple myeloma.

Journal: IDCases

Published: July 21, 2026

Multidisciplinary Rehabilitation for Severe Respiratory Failure Due to Dasatinib-Induced Pulmonary Toxicity: A Case Report.

Multidisciplinary Rehabilitation for Severe Respiratory Failure Due to Dasatinib-Induced Pulmonary Toxicity: A Case Report.

Journal: The American journal of case reports

Published: July 09, 2026

Frontline daratumumab, lenalidomide, and dexamethasone in patients older than 80 years with newly diagnosed multiple myeloma: treatment durability, infectious complications, and nutritional vulnerability.

Frontline daratumumab, lenalidomide, and dexamethasone in patients older than 80 years with newly diagnosed multiple myeloma: treatment durability, infectious complications, and nutritional vulnerability.

Journal: Blood research

Published: June 17, 2026

Efficacy of fostamatinib add-on for TPO receptor agonist-refractory immune thrombocytopenia

Efficacy of fostamatinib add-on for TPO receptor agonist-refractory immune thrombocytopenia

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 04, 2026

Red blood cell transfusion and iron overload management in bone marrow failure diseases

Red blood cell transfusion and iron overload management in bone marrow failure diseases

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: January 12, 2026

Renal recovery and clinical outcomes with daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma with severe renal impairment.

Renal recovery and clinical outcomes with daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma with severe renal impairment.

Journal: International journal of hematology

Published: January 03, 2026

Safety and efficacy of clofarabine for preconditioning intervention in patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphoblastic leukemia.

Safety and efficacy of clofarabine for preconditioning intervention in patients undergoing allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute lymphoblastic leukemia.

Journal: International journal of hematology

Published: September 19, 2025

Overview

Overview

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 06, 2025

Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia.

Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia.

Journal: Annals of hematology

Published: July 05, 2025

Real-world treatment patterns and outcomes of patients with LR-MDS in Japan: an electronic health record database study.

Real-world treatment patterns and outcomes of patients with LR-MDS in Japan: an electronic health record database study.

Journal: International journal of hematology

Published: April 17, 2025

Comparison of clinical outcomes between preemptive and maintenance therapy after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.

Comparison of clinical outcomes between preemptive and maintenance therapy after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.

Journal: International journal of hematology

Published: January 09, 2025

Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms.

Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms.

Journal: British journal of haematology

Published: December 09, 2024

Showing 1-12 of 74

Last Updated: 09/26/2026